SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-136816
Filing Date
2021-04-28
Accepted
2021-04-28 16:01:52
Documents
4
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d93877ddef14a.htm DEF 14A 797884
2 GRAPHIC g93877g09k74.jpg GRAPHIC 75026
3 GRAPHIC g93877g45a53.jpg GRAPHIC 47723
4 GRAPHIC g93877g94y86.jpg GRAPHIC 83355
  Complete submission text file 0001193125-21-136816.txt   1079130
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38722 | Film No.: 21864129
SIC: 2836 Biological Products, (No Diagnostic Substances)